TTF1 and non-small cell lung carcinoma: However, there has been no evaluation of the impact of TTF-1 expression on the therapeutic effect of immunotherapy alone or chemotherapy in patients with NSCLC with high PD-L1 expression who are strongly affected by immunotherapy.